Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer.

Vairaktaris E, Serefoglou Z, Avgoustidis D, Yapijakis C, Critselis E, Vylliotis A, Spyridonidou S, Derka S, Vassiliou S, Nkenke E, Patsouris E.

Oral Oncol. 2009 Mar;45(3):247-53. doi: 10.1016/j.oraloncology.2008.05.003. Epub 2008 Jul 31.

PMID:
18674955
2.

Effect of thrombosis-related gene polymorphisms upon oral cancer: a regression analysis.

Vylliotis A, Yapijakis C, Nkenke E, Nisyrios T, Avgoustidis D, Adamopoulou M, Ragos V, Vassiliou S, Koronellos N, Vairaktaris E.

Anticancer Res. 2013 Sep;33(9):4033-9.

PMID:
24023347
3.

Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma.

Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S, Vylliotis A, Derka S, Vassiliou S, Nkenke E, Patsouris E.

J Cancer Res Clin Oncol. 2008 Aug;134(8):821-32. doi: 10.1007/s00432-008-0360-z. Epub 2008 Feb 14.

PMID:
18273643
4.

Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.

Vairaktaris E, Yapijakis C, Vasiliou S, Derka S, Nkenke E, Serefoglou Z, Vorris E, Vylliotis A, Ragos V, Neukam FW, Patsouris E.

Anticancer Res. 2007 Nov-Dec;27(6B):4095-100.

5.

The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.

Nishizawa R, Nagata M, Noman AA, Kitamura N, Fujita H, Hoshina H, Kubota T, Itagaki M, Shingaki S, Ohnishi M, Kurita H, Katsura K, Saito C, Yoshie H, Takagi R.

BMC Cancer. 2007 Oct 5;7:187.

6.

Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.

Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, Nkenke E, Ragos V, Vylliotis A, Spyridonidou S, Tsigris C, Yannopoulos A, Tesseromatis C, Neukam FW, Patsouris E.

Anticancer Res. 2007 Jan-Feb;27(1A):459-64.

7.

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.

Vairaktaris E, Yapijakis C, Tsigris C, Vassiliou S, Derka S, Nkenke E, Spyridonidou S, Vylliotis A, Vorris E, Ragos V, Neukam FW, Patsouris E.

Acta Oncol. 2007;46(8):1097-102.

PMID:
17851834
9.

Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans.

Vairaktaris E, Yapijakis C, Yiannopoulos A, Vassiliou S, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Critselis E, Avgoustidis D, Neukam FW, Patsouris E.

Oncol Rep. 2007 Apr;17(4):963-8.

PMID:
17342343
10.

Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.

Supic G, Jovic N, Zeljic K, Kozomara R, Magic Z.

Oral Oncol. 2012 Nov;48(11):1171-7. doi: 10.1016/j.oraloncology.2012.05.023. Epub 2012 Jul 18.

PMID:
22818823
11.

Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.

Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R, Giusti B.

J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.

12.

Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer.

Weng CJ, Chen MK, Lin CW, Chung TT, Yang SF.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S319-27. doi: 10.1245/s10434-011-1736-x. Epub 2011 Apr 22.

PMID:
21512861
13.

A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.

Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, Vylliotis A, Yapijakis C, Neukam FW, Patsouris E.

Eur J Surg Oncol. 2008 Apr;34(4):450-5. Epub 2007 May 11.

PMID:
17498910
14.

Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.

Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P, Neukam FW.

Oral Oncol. 2006 Oct;42(9):888-92. Epub 2006 May 26.

PMID:
16730474
15.

Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas.

Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW.

J Oral Pathol Med. 2004 Jul;33(6):323-6.

PMID:
15200479
16.

Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.

Kietthubthew S, Sriplung H, Au WW, Ishida T.

Int J Hyg Environ Health. 2006 Jan;209(1):21-9. Epub 2005 Aug 15.

PMID:
16373199
17.

Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.

Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.

Carcinogenesis. 2004 Dec;25(12):2379-84. Epub 2004 Aug 19.

PMID:
15319295
18.

Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.

Srivastava P, Kapoor R, Mittal RD.

Gene. 2013 Nov 10;530(2):273-7. doi: 10.1016/j.gene.2013.06.087. Epub 2013 Jul 17.

PMID:
23872201
19.

The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population.

Lin YC, Yeh CJ, Wang LH, Lee CW, Chen CH.

Oral Oncol. 2012 Jun;48(6):535-40. doi: 10.1016/j.oraloncology.2012.01.008. Epub 2012 Feb 8.

PMID:
22321253
20.

The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.

Vairaktaris E, Yapijakis C, Serefoglou Z, Derka S, Vassiliou S, Nkenke E, Vylliotis A, Wiltfang J, Avgoustidis D, Critselis E, Neukam FW, Patsouris E.

Eur J Surg Oncol. 2007 May;33(4):504-7. Epub 2006 Dec 14.

PMID:
17174061

Supplemental Content

Support Center